Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6226
CALL
Traeger
COOK
$155M
| $1.37M | ﹤0.01% |
6,426
-72
| -1% | -$20.1K |
|
6227
Energy Transfer Partners
ET
$72.1B
| $1.37M | ﹤0.01% |
136,875
-6,232,939
| -98% | -$69.8M |
|
6228
First Trust Preferred Securities and Income ETF
FPE
$6.31B
| $1.37M | ﹤0.01% |
79,256
-45,413
| -36% | -$821K |
|
|
YMAB
6229
CALL
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.37M | ﹤0.01% |
90,300
-89,800
| -50% | -$1.05M |
|
6230
PUT
Domo
DOMO
$179M
| $1.36M | ﹤0.01% |
49,100
+29,700
| +153% | +$1.09M |
|
6231
CALL
LCI Industries
LCII
$2.53B
| $1.36M | ﹤0.01% |
12,200
+5,900
| +94% | +$645K |
|
6232
CALL
iShares Russell Mid-Cap ETF
IWR
$58.1B
| $1.36M | ﹤0.01% |
21,100
-900
| -4% | -$64.1K |
|
|
TBCH
6233
Turtle Beach Corp
TBCH
$219M
| $1.36M | ﹤0.01% |
111,545
+43,198
| +63% | +$735K |
|
|
BCYC
6234
CALL
Bicycle Therapeutics
BCYC
$280M
| $1.36M | ﹤0.01% |
81,200
+64,000
| +372% | +$1.35M |
|
6235
PUT
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
| $1.36M | ﹤0.01% |
37,500
+5,000
| +15% | +$201K |
|
6236
PUT
Vroom Inc
VRM
$50.6M
| $1.36M | ﹤0.01% |
13,636
-2,074
| -13% | -$260K |
|
|
WINC
6237
DELISTED
Western Asset Short Duration Income ETF
WINC
| $1.36M | ﹤0.01% |
57,515
+25,579
| +80% | +$616K |
|
6238
BlueLinx
BXC
$670M
| $1.36M | ﹤0.01% |
20,377
-24,802
| -55% | -$1.86M |
|
6239
Dimensional International Small Cap Value ETF
DISV
$5.19B
| $1.36M | ﹤0.01% |
64,634
+35,230
| +120% | +$816K |
|
6240
CALL
Impinj
PI
$5.25B
| $1.36M | ﹤0.01% |
23,200
-11,000
| -32% | -$553K |
|
|
PMT
6241
CALL
PennyMac Mortgage Investment
PMT
$839M
| $1.36M | ﹤0.01% |
98,400
+5,200
| +6% | +$79.4K |
|
|
CPRX
6242
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.36M | ﹤0.01% |
193,949
-19,463
| -9% | -$143K |
|
|
CDK
6243
PUT
DELISTED
CDK Global, Inc.
CDK
| $1.36M | ﹤0.01% |
24,800
-94,200
| -79% | -$5.09M |
|
6244
First Trust Switzerland AlphaDEX Fund
FSZ
$37.3M
| $1.36M | ﹤0.01% |
25,631
-4,826
| -16% | -$281K |
|
6245
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.98B
| $1.36M | ﹤0.01% |
22,261
+16,549
| +290% | +$1.11M |
|
6246
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.13B
| $1.36M | ﹤0.01% |
+50,183
| New | +$1.43M |
|
6247
CALL
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$217M
| $1.36M | ﹤0.01% |
18,660
+13,920
| +294% | +$826K |
|
6248
Nomura Holdings
NMR
$28.7B
| $1.36M | ﹤0.01% |
378,704
-197,829
| -34% | -$755K |
|
6249
PUT
Upbound Group
UPBD
$1.13B
| $1.36M | ﹤0.01% |
69,700
+16,200
| +30% | +$403K |
|
|
AGNT
6250
CALL
AGNT Inc
AGNT
$710M
| $1.35M | ﹤0.01% |
115,100
-35,100
| -23% | -$508K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.